Ascorbate sensitizes human osteosarcoma cells to the cytostatic effects of cisplatin
Abstract Osteosarcoma (OS) is the most common malignant bone tumor and a leading cause of cancer‐related deaths in children and adolescents. Current standard treatments for OS are a combination of preoperative chemotherapy, surgical resection, and adjuvant chemotherapy. Cisplatin is used as the stan...
| Váldodahkkit: | , , , , , , , , , |
|---|---|
| Materiálatiipa: | Artihkal |
| Giella: | English |
| Almmustuhtton: |
Wiley
2020-08-01
|
| Ráidu: | Pharmacology Research & Perspectives |
| Fáttát: | |
| Liŋkkat: | https://doi.org/10.1002/prp2.632 |